YCYvang Chang

Yvang Chang

*This is an algorithmically generated author record based on publicly available information.

Yvang Chang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Incidence and risk factors of surgical site infection following cervical laminoplasty: A retrospective clinical study

    by Jinzuo Wang, Yvang Chang, Moran Suo, Huagui Huang, Xin Liu, Zhonghai Li

    There are many debates regarding the risk factors of surgical site infection (SSI) following posterior cervical surgery in previous studies. And, till now there is no such a study to examine cervical laminoplasty surgery. From January 2011 through October 2021, a total of 405 patients who were treated with unilateral open‐door laminoplasty surgeries were enrolled in this study. We divided the patients into the SSI group and the non‐SSI group and compared their patient‐specific and procedure‐specific factors. Univariate and multiple logistic regression analysis were performed to determine the risk factors. Of the 405 patients, 20 patients had SSI. The rate of SSI found to be 4.93%. There were significant differences between groups in the thicker subcutaneous fat thickness (FT) ( p < 0.001), the higher ratio of subcutaneous FT to muscle thickness (MT) ( p < 0.001), the higher preoperative Japanese Orthopaedic Association (JOA) Scores ( p < 0.003), the decreased preoperative serum albumin ( p < 0.001), the more postoperative drainage ( p < 0.05) and the longer time of draining ( p < 0.001). Logistic regression analysis of these differences showed that the higher ratio of subcutaneous FT/MT, the higher preoperative JOA scores, the decreased preoperative serum albumin and the longer time of draining were significantly related to SSI ( p < 0.05). The higher ratio of subcutaneous FT/MT, the higher preoperative JOA scores, the decreased preoperative serum albumin and the longer time of draining are identified as the independent risk factors of SSI in cervical laminoplasty. Identification of these risk factors could be useful in reducing the SSI incidence and patients counselling.


  • Open Access

    The Dual Effect of Abnormal Serum Uric Acid on Intervertebral Disc Degeneration

    by Ming Yang, Naiguo Wang, Wentao Zhang, Tianze Sun, Dan Zhang, Yvang Chang, Jingmin Li, Zhonghai Li

    An abnormal serum uric acid (SUA) level is associated with many diseases. To our knowledge, there is no research on the association between SUA and intervertebral disc degeneration (IDD). The purpose of this study was to determine the relationship between SUA and IDD. From June 2011 to July 2020, 691 patients undergoing surgery for lumbar disc herniation (LDH) were included in the LDH group, and 684 patients who underwent endoscopic surgery for knee trauma were included in the non‐LDH group. We examined the baseline characteristics of all these patients and divided the SUA level into 10 groups according to the percentiles in males, females, and the total population. Subsequently, the relationship between the SUA level and IDD was further analyzed. There was no statistically significant difference in the baseline characteristics of the two groups (p > 0.05). Among the 10 groups, the LDH rate was higher at both lower and higher SUA levels. In multiple logistic regression analysis, after adjustment for age, sex, body mass index, smoking, and drinking, when the SUA level was 80%, compared with 60–80%, the odds ratio (OR) and 95% confidence interval (CI) of LDH of the total population were 1.821 (1.125–2.946) and 1.701 (1.186–2.438), respectively, and in the males, they were 1.922 (1.169–3.161) and 2.800 (1.766, 4.439), respectively. In females, when the SUA was <20%, there was a higher LDH rate (OR = 1.951, 95% CI 1.091‐3.486). The present study suggests that there is a U‐shaped relationship between SUA and IDD, being particularly prominent among male. Lower and higher SUA level may be risk factors for IDD.


  • Open Access

    Effect of Platelet-Rich Plasma on Intervertebral Disc Degeneration In Vivo and In Vitro: A Critical Review

    by Yvang Chang, Ming Yang, Song Ke, Yu Zhang, Gang Xu, Zhonghai Li

    Intervertebral disc degeneration (IDD) is a globally occurring disease that represents a significant cause of socioeconomic problems. Currently, the main method for treating IDD is surgery, including discectomy and vertebral fusion. Several in vitro experiments demonstrated that platelet-rich plasma (PRP) could stimulate cell proliferation and extracellular matrix regeneration. Additionally, in vivo experiments have proven that PRP injection could restore intervertebral disc height. Clinical studies demonstrated that PRP injection could significantly relieve patient pain. However, further studies are still required to clarify the roles of PRP in IDD prevention and treatment. This review is aimed at summarizing and critically analyzing the current evidence regarding IDD treatment with PRP.


  • Does hyperuricemia correlate with intervertebral disc degeneration?

    by Yvang Chang, Ming Yang, Yu Zhang, Gang Xu, Zhonghai Li